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1. Introduction 
Over the past 12,000 years humans have gradually developed greater understanding and 
control over life. Agriculture, including plant and animal husbandry, were early important 
developments. Medicine also contributed to the control of life by fighting disease and more 
recently through technologies to control and manipulate fertility. Knowledge and 
technologies from physics and chemistry provide the tools to investigate biological 
processes at a molecular and even atomic level. Late 20th century and 21st century genetic 
science heralds remarkable advances in our understanding of life and our ability to control 
and manipulate it for our teleological endeavours. Emerging biotechnologies are in the 
foreground of modern scientific research. 
Evolutionary theory, Mendel’s laws of inheritance, the discovery of DNA, the mapping of 
the human genome, genetic engineering (GE) of organisms, gene therapy, synthetic biology, 
cloning, stem cell therapies, epigenetics, and life extension research are theories and 
technologies providing powerful new insights into the nature of life and the development of 
technologies to manipulate all aspects of life. This knowledge is deconstructing and 
reconstructing our knowledge of what life is and what it means to be human, and where 
humans sit in the order of nature. Table 1 lists a brief selection of important milestones in 
humanity’s understanding and control of life along with some loosely associated worldviews.  
Genetic technology has the potential to change biological and social reality. Its development 
and application have consequences for humans, other animals and the planetary biosphere. 
These consequences are open to moral evaluation, questions that may be asked include:  
what are the likely social and moral impacts? is this progress? are these consequences good 
or bad? does the potential good outweigh the potential bad? for whom? how fair are the 
consequences? how easily can they be accessed or avoided? and how do different social and 
biophysical contexts affect their moral status? Another relevant question is, can the positive 
consequences obtained by use of genetic technology be obtained using alternative 
technologies (perhaps with less potential for negative consequences)? These questions 
demonstrate that the practice of genetic science (and indeed science in general) is 
inextricably bound to moral reasoning, moral behaviour and technological foresighting.  
This chapter will investigate the social and moral issues that surround various aspects of 
new genetic technologies with a particular focus on genetic engineering. These technologies 
and moral questions will be considered in relationship to the sustainability imperative. 
Public moral attitudes to genetic engineering will be touched on and contrasted with those 
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of the science community. Finally, the chapter will conclude with a discussion on the rights 
and responsibilities of scientists in society. 
 
Biological Milestones Approx. date Associated worldview 
Agriculture – plant and animal 
husbandry 
10,000BC - Animistic/magical/mythological 
Ancient medicine (e.g.,Imhotep, 
Hippocrates, Galen) 
2500BC – 180AD Animistic/magical/mythological
/religious/Ptolemaic 
Medieval medicine (e.g., 
Avicenna, Ibn an-Nafis, 
Paracelsus) 
1000-1500AD Religious/Ptolemaic 
Renaissance  medicine (e.g., 
Vesalius to Jenner) 
1500-1800 
Darwin’s Theory of Evolutionary 1860 
Mendel’s Laws of inheritance 1865 
Pasteur invents vaccines 1880 
Morgan’ discovery of the 
chromosomes 
1915 
Religious/Copernican/scientific 
 
Fleming invents antibiotics 1928 
Watson and Crick discover DNA 1953 
Religious/Copernican/scientific/
modernist 
 
Fertility control – oral 
contraceptive, in vitro fertilisation
1960 
Genetic engineering 1971 
Copernican/scientific/modernist 
 
Tissue engineering 1987 
Gene therapy (1970) 1990 
Epigentics 1990 
Animal cloning 1996 
Stem cells therapy 1998 
Life extension 2000 
Synthetic biology 2000 
Copernican/scientific/post-
modernist 
 
Table 1. Selected milestones in the understanding and control of life, approximate dates and 
associated worldviews 
2. The rise of genetic science 
Darwin’s Theory of Evolution completely revised our notions of the nature of life and its 
origins. Species were no longer created individually by God, nor once ‘created’, were they 
fixed and immutable. No longer were we a unique and special creature, made in the image 
of a miraculous supernatural creator, rather, it became apparent that humans were one of 
approximately ten millions species inhabiting earth, evolving to fit selection pressures in a 
similar fashion to the other animals on the planet. Gregor Mendel’s laws of inheritance 
statistically demonstrated that characteristics could be passed on from one generation to  
the next. The discovery, in the early twentieth century by Thomas Hunt Morgan, of 
chromosomes and the genetic diversity engendered by sexual reproduction, and the mid  
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century discovery of DNA by Crick and Watson provided a causal mechanism for 
inheritance and a molecular level mechanism for Darwinian natural selection. Technology 
has enabled the genomes of organisms to be ‘read’ and compared, showing that humans 
share more than 98% of our genes in common with the chimpanzee (Jones, 2006), giving us 
new insights into our biological and moral position within nature.  
The Human Genome Project (HGP) achieved three major goals. First, it sequenced the order 
of all the 2.9 billion base pairs in the genome. Second, it developed maps locating genes for 
major section of all our chromosomes. Third, it produced ‘linkage maps’ enabling inherited 
traits to be tracked over generations. Francis Collins, the director of the HGP described the 
results and meaning of the HGP as: 
It's a history book - a narrative of the journey of our species through time. It's a shop 
manual, with an incredibly detailed blueprint for building every human cell. And it's a 
transformative textbook of medicine, with insights that will give health care providers 
immense new powers to treat, prevent and cure disease. 
(Cited by National Human Genome Research Institute, 2009) 
As the relationship between genes and individual health and behaviour becomes more 
apparent, moral questions arise as to who may have access to an individual’s genome, and 
what will they be able to do with this information. As significant a milestone as it is, 
sequencing of the genome merely marks a beginning. It will take many decades (and 
massive computer power) to understand how the approximately 20,000 genes in the human 
genome interact with one another to produce over two hundred thousand different proteins. 
A great deal is not currently understood about how the genome works. Long held theories 
continue to be questioned. For example, contrary to the last hundred years of scientific 
belief, Mendel’s Laws have recently been challenged. Although still believed to be 
fundamentally correct, it has been claimed that Mendel’s Laws are not absolute and 
exceptions occur (Lolle, Victor, Young, & Pruitt, 2005). Likewise, the idea of inherited 
acquired characteristics was for a long time considered biological and scientific heresy, but 
the received scientific dogma has been challenged by the new science of epigenetics 
(Jablonka & Raz, 2009; Kaati, Bygren, & Edvinsson, 2002; Lumey, 1992). Similarly, a dozen 
years ago, with perhaps a little scientific arrogance, molecular biologists designated long 
stretches of organisms’ genomes as “junk DNA” claiming that these non-coding segments 
served no purpose. However, it is logically obvious that human lack of knowledge about the 
function of elements of nature does not mean they lack function.   
Recently, research has shown important roles for junk DNA (Nowacki, et al., 2009), 
demonstrating the hubris of the junk DNA assumption. Indeed, it now appears that junk 
DNA plays a vital role in evolution (in particular enabling fast genetic adaptation to 
changing environmental circumstances) and will be crucial for the refining of GE 
techniques and for gene therapy (Feng, Naiman, & Cooper, 2009; Vinces, Legendre, 
Caldara, Hagihara, & Verstrepen, 2009). New evidence also suggests that the rDNA 
repeats known as “junk DNA” are essential for repairing the DNA damage caused by 
factors such as UV light (Ide, Miyazaki, Maki, & Kobayashi, 2010). The use of technologies 
with powerful potential to affect the physical and social worlds, without a good 
understanding of the science involved, has the potential for unexpected and unforeseen 
negative social and moral impacts. 
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3. Developments in genetic science and moral questions 
3.1 Genetic engineering 
The breeding of promising individuals over generations in order to create desirable 
phenotypic characteristics in plants and animals has long been practiced in horticulture and 
animal husbandry. This is a relatively slow process with progressive changes made over 
many generations, not by nature or natural selection, but by human intervention in the 
evolutionary progress of the species. Racehorses, domestic cattle, show dogs and the staple 
grains are prime examples of centuries and even millennia of breeding to slowly bend 
nature to the aesthetic tastes and teleological desires of humans. 
In the past forty years, with the discovery of recombinant DNA, humans have gained the 
power to make changes to an organism’s genome in a single generation. Genetic engineering 
(GE) involves the chemical addition or deletion of a specific gene from an organism’s 
genome in order to bring about a desired change in the organism’s phenotype. With this 
process organisms can have current characteristics enhanced or removed and even entirely 
new characteristics, not evident in the organism’s species, added. Thus, a gene from one 
species (or a synthetic analogue of the gene), may be spliced into the genome of the same or 
a different species, or even an organism from a different biological kingdom, giving the new 
GE organism phenotypic characteristics from the donor species (Small, 2004a). 
In this way GE can create organisms with desired attributes much more quickly than 
traditional breeding (i.e., in a single generation). This amounts to a speeding up of evolution 
in a direction decided by humans. This also differs from normal evolution and animal and 
plant husbandry in that the new organism does not co-evolve, in little steps, over time with 
the other organisms in its environment. Instead an evolutionary leap is engineered within a 
single generation. Another difference between GE and selective breeding is that organisms 
can be created that could not possibly have come about naturally, as organisms generally 
cannot breed with others from different species or kingdoms. Proponents see great hope for 
the common good of humanity in GE technology, and often claim that the technology will 
be necessary to produce enough food to feed the future population (Borlaug, 1997; Fedoroff, 
et al., 2010; Ortiz, 1998). 
While GE offers the potential to further bend nature to our desires, critical commentators 
express concern about negative extrinsic moral impacts. These include the potential to 
develop dangerous organisms, the impossibility of reversibility once such organisms are 
loose in the environment, and the potential for negative impacts on humans, other animals 
and the environment (Antoniou, 1996; Fox, 1999; Ho, 2000; Rifkin, 1998; Straughan, 1995b). 
Others criticise the technology from an intrinsic moral perspective; creating life is the 
province of ‘God’ or nature – human attempts to usurp the role of God or nature are seen as 
acts of hubris – against God or disrespectful to nature (Appleby, 1999; Straughan, 1995a). 
Currently GE is being used to engineer micro-organisms and bacteria (particularly for the 
production of medicines such as insulin, factor 9 clotting agent, human growth hormone, 
etc.), plants and animals for food production, production of medicines, industrial 
production and phytoremediation. An example of a potential GE food animal is the ‘eco-
friendly’ GE pig, engineered to contain bacteria which help pigs remove phosphate from 
their food, thus stopping it from passing through into the environment, where it causes 
harm to life in streams and rivers (Golovan, et al., 2001). Pigs have also been genetically 
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engineered to contain human genes, so that their organs will be less susceptible to immune 
system rejection when used for xenotransplantation (White, Langford, Cozzi, & Young, 
1995); the replacement of failing human organs with those from animals. 
Advocates of GE claim that the technology is safe. In 2008 GE crops were grown on 300 
million acres worldwide. GE crops have been consumed for over 13 years without any 
incident, it is claimed. Furthermore, production has increased and so have farmers’ profits, 
while pesticide and herbicide use have been reduced and the use of the no-till method of 
agriculture (helpful for reducing soil erosion) increased (Fedoroff, et al., 2010). However, so 
far the principal use of GE in food crops has been to engineer insect resistance (bt crops) or 
to make the crops resistant to a specific herbicide used to eliminate weeds from fields of 
growing crops – a major beneficiary being the company selling the proprietary herbicide 
and seeds (one and the same company – Monsanto). On the positive side, the herbicide for 
which resistance is engineered (Roundup or glyphosate) is relatively environmentally 
benign and the whole process eliminates the need for further applications of less 
environmentally benign herbicides. 
One possibility presented by GE is the enhancement of nutritional qualities of crops, as for 
example, the much heralded golden rice. Golden rice has been engineered to contain extra 
beta-carotene which converts to vitamin A when consumed by humans.  Many people in 
developing countries, where rice is the primary staple, suffer from vitamin A deficiency 
(Tang, Qin, Dolnikowski, Russell, & Grusak, 2009). Foods with genetically enhanced health 
qualities or with healthy additives are referred to as functional foods and the science of 
developing them and studying the relationship between food plant genes, health and the 
individual human genome is called nutrigenomics. Of course, the societal benefits of 
functional foods will be dependent upon the public’s acceptance of GE food. 
Genetic engineering for medical purposes is considerably more acceptable to the general 
public than GE of food crops (Small, Parminter, & Fisher, 2005). Proponents hope that 
numerous medicines will be able to be grown in GE plants and/or GE animals and 
produced more cheaply than through current techniques. A biotech company, SemBioSys, 
has submitted an Investigational New Drug application for safflower-produced 
recombinant human insulin to the U.S. FDA (SemBioSys, 2008). Edible vaccines (e.g., 
potatoes, tomatoes, bananas etc) are being developed for a range of diseases (e.g., cholera, 
measles, malaria, hepatitis B, type 1 diabetes etc) and are proposed as a logistically simpler 
resolution of the problem of getting vaccines to those in need in developing countries 
(Chowdhury & Bagasra, 2007; Levi, 2000). However, it remains unclear how vaccine dosages 
would be controlled and how accepting the public will be of the conflation of food and 
medicine. Nonetheless, biotech and pharmaceutical companies have high hopes for rich 
profit streams from genetically enhanced medical foods and functional foods. 
GE animals have been used as ‘bioreactors’ to produce medicines and industrial products. 
Cows, sheep and goats have been genetically engineered to produce human proteins in their 
milk for medical purposes (Wells, 2010). Silk worms have been genetically engineered to 
produce a form of the human protein collagen which scientists hope to harvest for 
applications such as artificial skin and wound dressings (Tomita, et al., 2003). The industrial 
sector also contains many potential applications for GE technology in terms of new methods 
of producing currently available materials, new materials with desirable qualities, and the 
production of chemicals and biofuels. For example, spider silk is stronger than steel and as 
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resilient as kevlar, but it is very expensive to produce. Scientist have placed artificial 
versions of silk genes in various plants (potatoes, tobacco) and animals (goats) and, using 
this technology, hope to be able to mass produce silk protein for the development of new 
biodegradable ‘super-materials’ (Scheller, Guhrs, Grosse, & Conrad, 2001). Gene engineered 
viruses have even been used to manufacture a ‘green battery’ which the authors claim is 
capable of powering an iPod three times as long as current iPod batteries (Lee, et al., 2009). 
However, some GE animals seem largely for human entertainment, for example, the first GE 
pet commercially available in the U.S. was a florescent red zebrafish called a GloFish 
(GloFish.com, 2010). A company called Lifestyle Pets has marketed a genetically engineered 
hypoallergenic cat. Given the history of animal breeding for traits of interest to humans, 
further such applications seem highly probable. Indeed, GE pets suggest mythological sized 
possibilities; anyone for a pet gryphon? Chimeras are indeed possible using genetic 
technologies, with a number of research projects having already created them (however, a 
gryphon might be a bit of a stretch). Of particular concern to some is the possibility of 
human-animal chimeras (Robert & Baylis, 2003). Robert and Baylis imagine a fusion 
between a chimp and a human. They suggest that there might be confusion over the status 
of such a creature and that it might lead to social disorder. However, Savulescu (2003) 
argues that there might be good reasons to create human chimeras. He suggests medical 
reasons (e.g., to confer resistance to specific diseases such as AIDS), to delay aging, or to 
enhance human capabilities.  
Clearly, a range of ethical questions are opened by the creation of chimeras. Undoubtedly, 
there will be a range of different responses to these questions. Another question some 
ethicists have raised regarding GE animals concerns respect for the telos of the animal.  Telos 
refers to the “genetically based drives or instincts that, if frustrated, would result in a 
significant compromise to the welfare of an animal” (Thompson, 2010, p. 817). Some 
ethicists claim that it may be morally acceptable to alter an animal’s telos  using GE so long 
as it enhances wellbeing (Rollin, 1998), while others have argued that it is not (Fiester, 2008). 
3.2 Gene therapy 
 Another possible target for GE is humans. There is the potential to treat human genetic 
disorders through GE and a related technology, gene therapy. GE is conducted on eggs or 
embryos whereas gene therapy is a technique that may be used to change the genome 
(germ-line cells i.e., eggs or sperm) or the somatic cells of particular organs (in vitro or in 
vivo) of a developing or already developed organism. Changes made to somatic cells using 
gene therapy are not inherited by the organism’s descendants (Gene Therapy Net, 2010). 
Gene therapy uses a vector (most usually a disabled virus) to ‘infect’ target cells with the 
desired gene. Genetic engineering has successfully produced germ-line changes in 
marmoset monkeys (Sasaki, et al., 2009). Gene therapy modifications, when conducted on 
germ-line cells, are also inherited by the organism’s descendants. Using such techniques 
hereditary diseases could be cured and eliminated from the germ-line and the disease 
potentially eliminated from a species (Gene Therapy Net, 2010). 
Despite some initial setbacks (Neimark, 2009) gene therapy is beginning to look very 
promising, with a number of recent successful trials. Gene therapy has succeeded in curing, 
amongst other things, some cases of ‘bubble boy syndrome’, a degenerative disease of vision 
called ‘Leber congenital amaurosis’, and a cancer of the blood called ‘EBV lymphoma’ 
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(Neimark, 2009).  The gene therapy drug ProSavin has been found effective for treating a 
monkey analogue of Parkinson’s Disease and is being trialled with human subjects (Jarraya, 
et al., 2009). Hope is high for the promise of gene therapy or GE to cure a number of deadly 
hereditary diseases including cystic fibrosis, hemophilia, Tay-Sachs, muscular dystrophy, 
multiple sclerosis and diabetes. Gene therapy may also be used to activate the immune 
system against infectious diseases and cancers and to trick the body into growing new tissue 
to heal wounds, repair injured hearts and rejuvenate arthritic joints (Neimark, 2009).  
3.3 Genetic enhancement  
Gene therapy has been used to give colour vision to naturally colour blind monkeys 
(Mancuso, et al., 2009), suggesting similar enhancements to human senses may be possible. 
Thus, besides therapeutic human GE, there is also the possibility of using GE to enhance 
humans. Given the money and prestige involved in sports, and given the human and 
political propensity for aggression, super athletes and super warriors spring to mind.  
Doubled muscled cattle (e.g., Belgium Blue) have 20% extra muscle mass, this is known to 
be caused by a mutation on bovine MSTN, the myostatin coding gene (Grobet, et al., 1997). 
Scientists have been able to create double muscled GE myostatin knockout mice 
(McPherron, Lawler, & Lee, 1997). These mice have muscles 2-3 times heavier than normal 
mice. While extremely rare in humans, at least two children are known to have this 
mutation naturally, exhibiting exceptional strength and speed (Associated Press, 2007; 
Schuelke, et al., 2004). This suggests a gene target for super-athletes and super soldiers.  
Several genes have been discovered in mice which, when manipulated by GE, improve 
brain performance by stimulating nerve fibre growth, enhancing problem solving and 
memory (Routtenberg, Cantallops, Zaffuto, Serrano, & Namgung, 2000). Between 40-80% of 
variation in human intelligence is believed attributable to genetic factors. A genome wide 
scan, involving 634 sibling pairs, identified two chromosomal regions (on chromosomes 2 
and 6) that explain variation in IQ (Posthuma, et al., 2005). These genes offer clues to 
increasing the intellectual potential of humans or ameliorating the effects of diseases such as 
Parkinson’s, Alzheimer’s, autism and dyslexia. While considerable moral debate is associated 
with therapeutic GE (i.e., curing disease), enhancement gene technologies create even 
greater moral concern for most people. Approximately 80% of New Zealand public and a 
similar percentage of New Zealand scientists either strongly disagreed or disagreed that it is 
acceptable to genetically engineer humans in order to enhance human capabilities (Small, 
2006). However, some ethicists argue that, if we can enhance humans, and so long as this 
promotes human wellbeing, then we have a moral obligation to enhance (Savulescu, 2005).  
Savulescu (2005) cites gene therapy experiments that turned lazy monkeys into workaholics 
and promiscuous rodents into monogamous ones. Clearly, there may be debate about what 
counts as an enhancement, and the line between therapy and enhancement is easy to blur. 
Another social and moral concern regarding enhancement is, who gets it? Only those who 
can afford it? Is it another means to increase the positional advantage of the wealthy over 
the poor? To what extent will people choose to alter their genomes or the genomes of their 
descendants? Will the wealthy, with access to enhancement, become a new type of human 
from the poor, thus enhancing human inequity at the genetic level? Enhancement raises 
social and moral issues of justice and fairness. A more extreme but less immediate concern 
is, will humans evolve (through genetic enhancement) into multiple separate species, unable 
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to breed with each other? What tensions might exist between separate species descended 
from homo sapiens? Enhancement is laden with social and moral questions. 
Given the aforementioned hubris regarding junk DNA and our current lack of 
understanding of how genes interact with one another to form a multitude of proteins, 
human considerations of the nature of genetic enhancements might also be deluded. Our 
efforts may well do more damage to our species than good. Time may tell. Of course, future 
knowledge may eliminate the threat of lack of knowledge. However, completely 
understanding the human genome may take some time yet – with approximately 2.9 billion 
‘letters’ the possible combinations and interactions within the genome are astronomical. 
3.4 Eugenics or conscious evolution? 
Another issue that concerns some people regarding genetic therapy and enhancement is 
the historically sinister shadow of eugenics. Eugenics “requires that natural selection be 
replaced by intentional human control” (Hansen, Janz, & Sobsey, 2008, p. S105). 
Somewhat perversely, human medical control is currently unintentionally replacing 
aspects of natural selection. Advanced medical interventions enable individuals who 
would have died before procreation to contribute to the human gene pool. Our moral 
concern for the health and wellbeing of individual members of our species, unfit under 
conditions of natural selection, unintentionally or incidentally negatively impacts the 
overall fitness of the human species.  
One thing is clear, new medical and genetic technologies gives us the power to consciously, 
(or unconsciously), manipulate the evolution of our species. Should we do it just because we 
can? Or is it too much of an intellectual, moral and ontological minefield? What might be the 
unintentional effects of such tinkering with human nature? If we do it, on what basis should it 
be done? Should individuals be free to design their own offspring and, if so, what degree of 
freedom should be allowed? Would it, for example, be acceptable for deaf parents to have 
their children genetically engineered to be deaf? What are the rights of the genetically 
engineered offspring in this regard? Who makes the decision and by what authority? 
Another possibility is that conscious human evolution might be ‘centrally controlled’ so that 
a uniformity remains about our species rather than allowing us the freedom to diverge into 
a range of new and different species which may have quite disparate capabilities and 
perhaps even needs. How much ‘central control’ would be acceptable? Will there come a 
time when specific genetic enhancements are enforced for the good of the species? Designer 
babies, conscious evolution and eugenics are complex moral topics raised by current 
scientific and technological development in the field of genetic science. 
3.5 Synthetic biology 
“Synthetic biology aims to design and build new biological parts and systems or to modify 
existing ones to carry out novel tasks” (Parliamentary Office of Science and Technology, 
2008, p. 1). Synthetic biology offers prospects for novel methods to produce food, drugs, 
chemicals or energy, environmental biosensors, and new therapeutic techniques. 
Engineering principles may be used to build standardised interchangeable segments of 
DNA for use as biological building blocks to make new, or alter existing, organisms. DNA 
sequences (potentially even whole genomes) can be designed on computers and 
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manufactured in chemical laboratories. It is possible to construct the genome of a medium-
size virus in about three weeks (Parliamentary Office of Science and Technology, 2008). 
The potential for the malevolent use of synthetic biology is clear. In 2002, researchers from 
the University of New York constructed the poliovirus by following a recipe downloaded 
from the Internet using synthetic gene sequences sourced from a mail-order supply firm. 
Their purpose was to show how easily terrorists could create deadly biological weapons 
(Cello, Paul, & Wimmer, 2002). It is conceivable, that in the future, entirely new forms of 
life might be created in the laboratory using the techniques of synthetic biology (Chopra & 
Kamma, 2006). Synthetic biology attracts the ‘do it yourself’ brigade’, including groups 
with such exciting names as: OpenWetWare (OpenWetWare, 2009), DIYbio (DIYbio, 2010), 
Biopunk (Biopunk.org, n.d.), and Biohack (Bishop, 2008). Synthetic biologists in California 
are about to launch an open source biological production facility called BIOFAB 
(International Open Facility Advancing Biotechnology). BIOFAB “aims to boost the ease of 
bioengineering with "biological parts" that are shared resources, standardized and reliable 
enough that they can be switched in and out of a genome like electronic parts in a radio” 
(Katsnelson, 2010). 
J. Craig Venter, who led the private research project to decipher the human genome in 
competition with the publically funded project, has been working on creating the world’s 
first synthetic organism since 1995. He envisaged creating organisms that have the ability to 
manufacture biofuels and other useful compounds. He claims a “new design phase of 
biology” is about to begin (quoted by Grant, 2008). On May 21, 2010, Venter’s team 
published details of the creation of a synthetic genome that began replicating and producing 
proteins (Gibson, et al., 2010). Although many useful organisms may be created, the 
possibility of dangerous ones being created either accidentally or deliberately, is also very 
real. The Oxford ethicist, Savulescu, reflecting on the achievement of Venter’s team said: 
Venter is creaking open the most profound door in humanity’s history, potentially peeking 
into its destiny. He is going towards the role of a god: creating artificial life that could never 
have existed naturally. The potential is in the far future, but real and significant: dealing 
with pollution, new energy sources, new forms of communication. But the risks are 
unparalleled. (quoted by Henderson, 2010) 
Savulescu continued: 
We need new standards of safety evaluation for this kind of radical research and protections 
from military or terrorist misuse and abuse. These could be used in the future to make the 
most powerful bioweapons imaginable. The challenge is to eat the fruit without the worm. 
(quoted by BBC News, 2010) 
Biosecurity, biosafety, intellectual property, stakeholder engagement and involvement, 
unforeseen harmful consequences, human malevolent use of the technology and 
technological governance are among the serious ethical issues facing synthetic biology. 
3.6 Life extension 
Impressive work is currently being conducted in the area of life extension (de Grey, 2005; 
Finkel, 2003). The average life span in the developed countries has been steadily increasing 
and current projections are that someone born today could potentially live much longer 
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than the current maximum natural full term of around 120 years. It has long been known 
that calorie restriction (CR) diets can improve the health (in particular reduction of cancers 
and increased immunity) and extend the life of most mammals by up to 40% (Weindruch, 
Walford, Fligiel, & Guthrie, 1986). Recently a molecular level epigenetic mechanism for the 
effects of CR has been proposed (Li, Liu, & Tollefsbol, 2009), glucose restriction produced 
increased expression of hTERT (human telomerase reverse transcriptase). This provides 
targets for drugs for life extension. 
Telomerase is an enzyme that is responsible for the formation of the telomere DNA 
sequence. This sequence forms a cap on the ends of chromosomes. Telomeres are 
responsible for maintaining genomic stability and regulating cellular division. As somatic 
cells divide the telomere sequences get shorter and shorter, limiting cells to a fixed number 
of divisions (Harley, Futcher, & Greider, 1990). Cellular senescence and eventually death 
occur when telomeres reach a critical value. Heritability of telomeres is strong with studies 
estimating it at 40-80%  (Codd, et al., 2010). This is thought to be an important component of 
aging at a cellular level. Cancer cells preserve their telomeres no matter how many times 
they divide (i.e., they are immortal). Cancer cells have increased telomerase activity, thus 
suggesting a possible mechanism for increasing the longevity of normal cells. 
A number of genes have been shown to be related to the aging process, the health of 
individuals throughout their lifespan, and the overall length of lifespan. By manipulating 
specific genes in various organisms scientist have been able to greatly increase their lifespan. 
Adding an additional sir-2.1 gene to the genome of C. elegans (a nematode worm), led to a 
50% increase in lifespan (Tissenbaum & Guarente, 2001). Decreasing the activity of the daf-2 
gene led to a doubling of the lifespan of C. elegans (Kenyon, Chang, Gensch, Rudner, & 
Tabtiang, 1993). Single genes which have significant lifespan effects in fruit flies have also 
been discovered. Mutants fruit flies, with reduced activity (down regulation) of the mth 
gene (the methuselah gene), have a 35% increase in average lifespan and increased 
resistance to stressors such as starvation and heat (Lin, Seroude, & Benzer, 1998). Reduced 
expression of the Indy (I’m not dead yet) gene doubles the fly’s lifespan with no noticeable 
negative side effects (Rogina, Reenan, Nilsen, & Helfand, 2000). 
Helfand & Inouye  (2003, p. 276) claim that “There is great conservation between different 
organisms suggesting that what is learned in one model system will be true for others.” 
Research with healthy centenarians (and their very old - 91+ siblings), using genetic linkage 
analysis, found a region on chromosome 4, that contains between 100 and 500 genes, 
associated with extra long healthy lives (Puca, et al., 2001). In the past few years a handful of 
these genes have been identified as important to the aging process (Rucz, 2008). Genetic 
engineering, gene therapies and stem cell therapies are expected to play a significant role in 
life extension in terms of rejuvenation of aging or diseased cells and organs and elimination 
of genetic disorders. Significantly increasing human life spans raises moral problems of 
justice and fairness in a world still undergoing exponential human population growth and 
facing depletion of the resources necessary for survival. 
3.7 Patenting genes 
An important ethical, legal and economic issue with implications for the practice of science, 
the dissemination of scientific knowledge, and medical practice, is the question of 
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patenting genes and gene sequences (Schacht, 2006). According to an article in Nature 
Biotech, in the year 2000, over 6000 gene patents had been granted with over 1000 of these 
specifically related to human genes and more than 20,000 gene patents were pending at 
that time (Grisham, 2000). While commercial biotech companies are strongly in favour of 
being able to patent genes, claiming that it is necessary in order to fund research and 
innovation (Schacht, 2006), many scientists and scientific bodies are opposed to it, claiming 
that patenting slows the progress of science by restricting open access and use of the genes 
in further research. 
Physicians and patients also claim that patenting of genes restricts patients’ access to 
medical care (Andrews, 2002; Leonard, 2002; Wadman, 2010). Others are strongly opposed 
to patenting genes on the principle that ‘no one should be able to patent life’ and that genes 
are products of nature and are merely discovered by humans and are, therefore, not 
patentable, as inventions are (Ho, 2000; Wadman, 2010). Some object that the ‘patenting of 
life’ “turns organisms, including human parts, into saleable commodities” (Ho, 2000, p. 30).  
The topic of gene patenting remains controversial and undecided. It will continue to pose 
legal, social, moral and economic issues for some time to come.  
3.8 Genetic engineering and technological convergence 
There are a range of powerful new technologies under development that in convergence 
will enhance both the power and availability of genetic engineering and other cell based 
technologies. Two of particular importance are nanotechnology and information technology. 
Computer processor power has undergone exponential growth since 1965 when Gordon 
Moore first stated the principle that has become known as Moore’s Law; the number of 
transistors on a chip doubles every two years. This law is still holding true. Also in 1965, I. J. 
Good proposed a concept that has become known as ‘the technological singularity’. This is  
the point in time when computers become more intelligent than humans, and hence better 
able than humans to develop their own intellectual capacity, eventually giving rise to super 
intelligent machines, fostering a near infinite rate of knowledge innovation (Good, 1965). 
Some futurists consider the technological singularity will occur in the not so distant future. 
Vinge (1993) predicts 2030 while Kurzweil (2005) predicts 2045. Computers with this level of 
processing power may enable an understanding and prediction of the interaction of genes 
leading to a vastly enhanced understanding of genetics and increasing the potential use and 
power of genetic engineering and related technologies.  
Similarly, in the rapidly advancing area of nanotechnology, new tools are being developed 
that will enhance our understanding and ability to control molecular and cellular behaviour. 
Nanotechnology will play an important role in the field of tissue engineering and organ 
regeneration through the generation of biomaterial scaffolding to maintain and regulate cell 
behaviour such as apoptosis, proliferation and differentiation (Chen, Mrksich, Huang, 
Whitesides, & Ingber, 1997; McBeath, Pirone, Nelson, Bhadriraju, & Chen, 2004). Small and 
Jollands (2006) argued that convergence will make these technologies, including genetic 
engineering, more accessible to an ever widening population. Such accessibility will 
enhance the ability of the ‘do it yourself’ brigade to genetically engineer and ‘biohack’ life. It 
will also make it increasingly easier for terrorists and others with malevolent intent to use 
GE technology to cause great harm. 
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3.9 Genetic engineering and some potential planetary threats 
Sustainability has become an ecological, social and moral imperative of our times 
(Lubchenco, 1998; The World Commission on Environment and Development, 1987). There 
is currently a range of potential threats to the sustainability of human and other life on earth 
(Bostrom, 2002; Brown, 2008; Rees, 2003). These threats are related to the increasing number 
of humans inhabiting Earth and our technological power to effect and impact nature (Small 
& Jollands, 2006). Main threats include resource depletion, deforestation, land and soil 
depletion, species extinction, pollution, peak oil, and climate change (Brown, 2008; Rees, 
2003). Human behaviour, in particular fossil fuel pollution, is causing climate change, global 
warming, ice melt, rising sea levels and ocean acidification (Intergovernmental Panel on 
Climate Change, 2007). These changes will make it increasingly difficult to produce enough 
food to feed the increasing human population (Fedoroff, et al., 2010; The Royal Society, 
2009). Despite the negative impacts of fossil fuel use, without oil it is estimated that the 
planet can only feed 2-3 billion people (Youngquist, 1999). 
The optimistic potential of GE crop production is the development of conventional breeding 
varieties of crops that are resistant to heat, salinity, drought, disease, pests and toxic heavy 
metals (The Royal Society, 2009). GE may also be able to increase the effectiveness of plants 
to extract necessary minerals for growth (such as nitrogen and phosphorus) enabling them 
to be grown on poorer quality soils using less fertiliser (West, 2010). The Royal Society 
claimed that the world needs genetically engineered crops to minimise environmental 
impacts and increase food yields to meet the challenge of feeding another 2.3 billion people 
by 2050 (The Royal Society, 2009). Another recent paper in the journal Science made similar 
claims (Fedoroff, et al., 2010). Noting that many important crops have sharp declines in 
production (20-30%) once the temperature exceeds 30 degrees Celsius, they claimed global 
warming will drastically reduce production in tropical and sub-tropical zones by the mid 
21st Century, causing food scarcity. 
Fedoroff et al. (2010) claimed that a radical rethink of agriculture is required. They argued 
for the development of crops which are heat, salt and drought tolerant and which do not 
require the current high levels of chemicals and fertilisers. Genetic engineering is their 
preferred radical strategy. They stated that GE will be necessary in order to produce crops at 
current production levels, let alone the production levels required in 2050  (Fedoroff, et al., 
2010). Given the likelihood of significant future temperature increases (Anderson & Bows, 
2008; J. Hansen, et al., 2008; Intergovernmental Panel on Climate Change, 2007), water 
shortages (Brown, 2008; Gleick, 2003; Vorosmarty, et al., 2004), salinity and degraded soil 
conditions in many of the world’s major growing regions (Lal, 2007; Pimentel & Sparks, 
2000), genetic engineering of crops is certainly an appropriate research strategy. 
However, Fedoroff, et al’s. (2010) arguments may be queried on several accounts. First, they 
made their claims about the necessity of GE without considering possible viable alternatives. 
Second, they ignored the impact of fossil fuel depletion on food production (Pimentel & 
Pimentel, 1996; Pimentel, Pimentel, & Karpenstein-Machan, 1999; Youngquist, 1999). This is  
a factor which would further add to their pessimism about actually being able to achieve the 
goal of feeding the planet’s population in 2050. Currently available GE crops are heavily 
dependent on oil products for their success. Third, they omitted to point out that, so far, no 
commercial GE plant crops have the particular attributes that they claimed will be beneficial 
(however, research is being conducted to this end and GE crops may well have these 
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attributes in the future). Fourth, they made their case sound more favourable by failing to 
note that the beneficial attributes they proposed are attributes that increase the fitness of 
plants and, therefore, increase the probability that horizontal gene transfer to weedy 
relatives will also make problem weeds fitter. 
Further, it is clear that, even if GE technology did contribute to enable production of 
adequate supplies of food to feed the population of 2050, there is no guarantee that 
economic and political action would not thwart these good intentions. Indeed, that is the 
very reason that, despite the currently adequate food supply, over a billion people still 
suffer from hunger and thousands starve to death each day (May, 1999). Although it is no 
reason to stop this line of GE research, there is abundant evidence that having a 
technological solution to a problem is no guarantee that humans will implement it. If people 
have no land to produce food themselves, or no money to buy it, they will likely starve, 
irrespective of any biotechnological bounty. No matter how useful the technology 
potentially is, the crucial issue is how people will choose to use it. Currently, economics 
trumps morals. 
This well known political fact is probably a major reason why approximately 60% of both 
the New Zealand public and New Zealand scientists are either sceptical or uncertain about 
the claim posited by some scientists’ that ‘GE will help solve the world’s food problems’. 
Regarding this statement a survey of the New Zealand public (n=860) found 9% strongly 
agreed, 29% agreed, 22% neither agreed nor disagreed, 21% disagreed, 11% strongly 
disagreed and 7% did not know (Small, 2009). This survey was conducted in May 2005 at the 
same time as a survey of NZ scientists (n=733) which also asked the same question. A very 
similar level of scepticism was also evident amongst NZ scientists; only 6% strongly agreed, 
33% agreed, 24% neither agreed nor disagreed, 21% disagreed, 10% disagreed strongly and 
6% did not know (Small & Botha, 2006). 
Nonetheless, GE has the potential to help address several of the planetary threats noted 
above (including food production). Synthetic genetic organisms could be used to produce 
fuel to help replace petroleum with bioethanol, butanol and other such products (Sticklen, 
2008). Genetically engineered plants could also be used for phytoremediation of polluted 
soils (Cherian & Oliveira, 2005). Some have suggested that genetically engineered trees may 
be able to help sequester greater amounts of carbon from the atmosphere – helping to 
reduce a major cause of climate change and global warming (Jansson, Wullschleger, Kalluri, 
& Tuskan, 2010). While it would clearly be better to not create these problems in the first 
place, rather than relying on a ‘technological fix’ being developed in the future, given the 
current problems and their magnitude and urgency, it would be foolish not to continue with 
GE research that may help us address these issues. 
3.10 Genetic engineering and the potential for harm 
Despite having a large range of intentionally positive applications, it is also clear that GE 
and gene therapy could create harm in the world through accidental unforeseen and 
unintended side effects, incidental effects – known side effects associated with positive 
intentional effects, or from malevolent intent (Small & Jollands, 2006). For example, scientists 
experimenting with the mouse pox virus (a mouse analogue of smallpox in humans) 
accidentally succeeded in making the virus much more virulent and deadly –killing even 
mice vaccinated against the disease (Jackson, et al., 2001).  
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Area of 
application 
Tech/product Potential benefits Potential harms 
GE crops Increased production 
Less pesticides and 
herbicides 
Less fertilisers 
No till Agriculture 
(soil conservation) 
Environmentally 
resilient crops 
Crops with enhanced 
nutritional value 
Extrinsic 
Resistant pests (evolve) 
Super weeds (outcrossing and escape) 
Irreversibility  
Single generation evolutionary 
impacts 
Conflation of food and medicine 
Lack of knowledge 
Accidental or incidental negative 
impacts on humans, animals, and 
environment 
Intrinsic and emotional 
Playing God 
Disrespectful to nature 
Morally/spiritually wrong 
Emotional yuk factor 
Food 
GE animals Increased production 
Healthier meat 
More resilient animals 
(less medicines, 
increased 
environmental 
tolerance) 
Extrinsic 
Reduced species diversity 
Single generation evolutionary 
impacts 
Conflation of food and medicine 
Lack of knowledge 
Accidental or incidental negative 
impacts on humans, animals, and 
environment 
Intrinsic and emotional 
Playing God 
Disrespectful to nature 
Disrespectful to animal telos 
Morally/spiritually wrong 
Emotional yuk factor 
Medicine Therapy 
Medicines 
derived from 
GE micro-
organisms, 
plants, animals.  
Gene therapy 
Stems cells  
Tissue 
engineering 
New medicines for  
curing illness, and 
injury 
Organ replacement 
Elimination of some 
diseases  
Increased life 
expectancy 
Extrinsic 
Outcrossing (and/or escape) 
Irreversibility  
Lack of knowledge 
Accidental or incidental negative 
impacts on humans, animals, and 
environment 
Zoonotic disease (e.g. from 
xenotransplantations) 
Overpopulation 
Malevolent actions (GE virus 
developed as weapon) 
Intrinsic and emotional  
Same as for GE food animals 
Table 2. (continues on next page) Some current applications of GE and some potential 
benefits and harms (note: these are meant to be illustrative rather than exhaustive) 
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Area of 
application 
Tech/product Potential 
benefits 
Potential harms 
Therapy 
Medicines derived 
from GE micro-
organisms, plants, 
animals.  
Gene therapy 
Stems cells  
Tissue engineering 
New medicines for 
curing illness, and 
injury 
Organ replacement 
Elimination of some 
diseases  
Increased life 
expectancy 
Extrinsic 
Outcrossing (and/or escape) 
Irreversibility  
Lack of knowledge 
Accidental or incidental negative impacts on 
humans, animals, and environment 
Zoonotic disease (e.g. from xenotransplantations) 
Overpopulation 
Malevolent actions (GE virus developed as weapon) 
Intrinsic and emotional  
Same as for GE food animals 
Medicine 
Enhancement 
Somatic and germ-
line therapy 
(enhanced physical, 
social mental 
capabilities, life 
extension)  
Chimeras 
Enhanced human 
(and non-human) 
capabilities 
Increased human 
resilience 
Disease elimination 
Promotion of human 
wellbeing 
Much increased life 
expectancy 
Extrinsic 
Super warriors 
Eugenics 
Lack of knowledge 
Accidental or incidental negative impacts on 
humans, Fairness/justice 
Autonomy 
Species divergence 
Potential enforcement 
Overpopulation 
Intrinsic and emotional 
Playing God 
Disrespect to nature 
Disrespectful to human telos 
Morally/spiritually wrong 
Emotional yuk factor 
Industry GE Pets  
GE plants, animals, 
micro-organisms for 
manufacturing  
Chemicals and  
materials  
Energy and fuels 
Synthetic biology 
Bioinformatics 
Biomimetics 
Pets with reduce 
allergic potential 
New and existing 
chemicals and 
materials with a 
range of new or 
enhanced properties 
Mitigation of peak oil
New production 
methods and 
processes 
Extrinsic 
Outcrossing or escape 
Dangerous organisms 
Irreversibility 
Competition between food and fuel for land and 
water Lack of knowledge 
Accidental or incidental negative impacts on 
humans, animals, and environment 
Malevolent bioweapons 
Intrinsic and emotional 
Same as for GE food crops 
Area of 
application 
Tech/product Potential benefits Potential harms 
Ecosystem 
services 
Phytoremediation 
Trees with enhanced 
carbon absorption 
Remediation of 
pollution and toxic 
sites 
Climate change 
mitigation 
Extrinsic 
Outcrossing or escape 
Irreversibility 
Lack of knowledge 
Unforeseen or incidental negative impacts on 
humans, animals, and environment 
Accidental or incidental negative impacts on 
humans, animals, and environment 
Malevolent application as bioweapons 
Intrinsic and emotional 
Playing God 
Disrespectful to nature 
Morally/spiritually wrong 
Table 2. (continued) Some current applications of GE and some potential benefits and harms 
(note: these are meant to be illustrative rather than exhaustive) 
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The potential to alter human smallpox or to combine genes from different diseases to create 
super diseases for the purpose of warfare or terror is clear and very real (malevolent intent). 
Indeed, it is reported the former Soviet Union succeeded in using recombinant DNA 
techniques to combine features of smallpox and Ebola (Katz, 2001). As Sir Martin Rees 
noted regarding biological and chemical weapons “A few adherents of a death-seeking 
cult, or even a single embittered individual, could unleash an attack” (Rees, 2003, pp. 48-
49). The possibility of creating lethal pathogens that target specific groups in society based 
on gene markers specific to that group also exists (Katz, 2001). Given the current racial and 
religious fanaticism demonstrated by some groups in society this is an extremely alarming 
possibility. 
Another a worrying trend is ‘do it yourself’ (DIY) bioengineering. Reportedly, home 
hobbyists (often without training in the field) are conducting GE and synthetic biology 
experiments from information and products found on the Internet and equipment 
constructed in home labs. Such experiments are conducted without regulation or control. 
These biohackers, as they call themselves, claim that the future Bill Gates of biotech could be 
developing a vaccine for cancer in their garage (Wohlsen, 2008). A worrying scenario is that 
synthetic organisms escaping from uncontrolled home GE labs could cause outbreaks of 
dangerous diseases and serious environmental damage. Table 2 presents some selected 
applications of GE technologies along with some potential benefits and some potential 
harms. 
3.11 Challenges to the development and use of GE technologies and products 
3.11.1 New Zealand public perceptions of GE and GE products 
In the preceding sections, I have considered some potential positive applications of genetic 
engineering, potential problems with some of these applications, and some potential 
negative applications of the technology. Of course, the examples considered are only a 
fraction of the potential applications, the potential benefits and the potential harms. 
However, from these examples, it is clear that GE technology may result in both benefit and 
harm. Next, I consider the challenges facing the adoption of GE technologies with 
applications that ostensibly are ‘for good’. Even for technologies with no harmful uses or 
side effects, in order for them to provide benefit there must be significant degrees of 
acceptance by society. People have to want and use the products that provide benefit. If 
people do not want the products then their development may be a very expensive waste of 
time and resources, which could be better spent elsewhere. 
A recent study conducted with a random sample the of New Zealand public (N = 1008) 
showed complex public attitudes to GE. Small (2009) asked respondents whether they had 
ever consumed GE food products and whether they had ever used GE medicines. The 
results are presented in Table 3. 
 
Technology Yes (%) No (%) Don’t know (%) 
Consumed GE food 20.2 12.1 67.7 
Used GE medicine 6.4 23.8 69.8 
Table 3. Percent of respondents consuming GE food and using GE medicine (N = 1008) 
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Most notable is that nearly 70% of respondents did not know whether they had consumed 
GE food or used GE medicines. Respondents were next asked their level of support for GE 
food and GE medicine. Results are presented in Table 4. 
 
Level of support GE food (%) GE medicine % 
Totally support it 7.3 26.2 
Support it in some circumstance 61.2 55.0 
Totally oppose it 20.8 9.4 
Don’t know 10.6 9.4 
Table 4. Percent of respondents supporting GE food and GE medicine (N = 1008) 
GE medicine is supported more strongly than GE food, with more respondents finding it 
acceptable than unacceptable. However, more respondents found GE food unacceptable 
than acceptable. Of note is the high percent of respondents who are prepared to support 
both GE food and GE medicine “under some circumstances” This indicates that although 
they have concerns about GE food and medicine they perceive that under some 
circumstances it may be justified. Also supporting this contention, 60% of the sample 
agreed that GE applications need to be considered on a case-by-case basis rather than 
totally supporting or totally opposing all applications of the technology. For 67% of the 
respondents their primary concern about GE was potential negative consequences for 
humans, animals, and the environment, only 6.5% considered their primary concern was 
that GE is in principle unethical, disrespects nature or is against God, while 26.1% did not 
have any major concerns about GE technology. Small (2009) also reported that respondents 
were neutral regarding “GE helping to cure disease” but sceptical about other proposed 
benefits such as “helping to feed the world”, being “environmentally friendly” and being 
“of more benefit than harm”.  
3.11.2 The practice of genetic science 
The technoethicist Mario Bunge held the position that although pure science “is 
intrinsically valuable, technology can be valuable, worthless, or evil, according to the ends 
it is made to serve. Consequently technology must be subjected to moral and social 
controls” (Bunge, 1977, p. 106). This is a teleological ethical argument. People may reject 
new technologies, including genetic engineering, for two main ethical reasons (Appleby, 
1999; Small, et al., 2005; Straughan, 1995a, 1995b). They may reject it for deontological 
(intrinsic) reasons (i.e., they consider the technology bad in itself, or an affront to God or 
nature) or for teleological (extrinsic) reasons (i.e., they believe the consequences of the use 
of the technology will be bad e.g., negative impacts on humans, animals or the 
environment). However, generally people tend to use both deontological and teleological 
reasoning when considering moral issues. When these two ethical perspectives are at odds 
with one another the individual may weigh the degree of perceived good and bad to reach 
a ‘balanced’ conclusion. Understanding public attitudes and moral perspectives may have 
important social consequences for the development and promulgation of powerful new 
technologies. The theoretical assumption of post-normal science (Funtowicz & Ravetz, 
1993) and the methods of empirical ethics (Borry, Schotsmans, & Dierickx, 2007) may help 
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provide understandings of public perceptions appropriate to policy development 
regarding genetic engineering. 
However, even applications of GE that are developed for good purposes may produce 
harm. Small and Jollands (2006) identified two primary ways in which technologies 
developed for good purposes may lead to harm. The first is through accidental causes, that is, 
unforeseen and unintended consequences, that are premised by a lack of knowledge or a 
lack of precaution regarding the use and potential consequences of the technology. The 
second is through incidental causes or coincidental effects of the technology. In this case 
there is awareness that the technology has potential harmful side effects, but nonetheless, 
we choose to use it for the perceived benefits (e.g., for many years leaded petrol was one 
such technological product). This highlights the importance of two related approaches to 
harm reduction associated with the development of powerful modern technologies. The first 
is foresight and the second is the precautionary principle. 
Jonas (1985) argued forcefully that, in order to respond to the techno-crises threatening 
nature and humans, a new ethic of scientific responsibility was necessary. Jonas’ (1985) 
insight, and a contention of the current work, is that modern technology changes the 
landscape of ethics. In the past, without modern technologies, the effects of human actions 
were proximally located in time and space and limited by their degree of control of energy 
and matter, as were their consequent impacts on human life and other conscious beings. 
Under such circumstances our moral responsibility need extend only as far as the effects of 
our actions. Now that humans possess sufficient power over nature as to affect the global 
conditions for human and non-human life, the far-off future and even the physical destiny 
of the planet, the framework of former ethics is no longer valid. 
Jonas (1985, p. x) claimed that to discharge this new moral responsibility “we must lengthen 
our foresight with a scientific futurology”, by which he meant using scientific knowledge about 
cause and effect relationships to extrapolate and attempt to predict future states associated 
with technological development. Bradshaw and Bekoff (2001) and Small and Jollands (2006) 
made the further claim that any such endeavour must take account of the psychology of 
human nature, as technological impacts on nature and humans arise from the application of 
technology by humans. Jonas acknowledged that, due to insufficiency of our predictive 
knowledge, foresight will always be uncertain and incomplete. Therefore, given the 
magnitude of what is at stake, he proposed that we should adopt a “pragmatic rule to give 
the prophesy of doom priority over the prophesy of bliss” (p. x). Foresight is a logical 
prerequisite for teleological ethical reasoning. Both Bunge and Jonas, like more recent 
technoethicists (e.g., Luppicini, 2008; Moor, 2005), claimed that, because of their role in 
developing technology, scientists have an extra responsibility (and perhaps accountability) 
regarding the social and moral impacts of technology. 
The precautionary principle is another proposed response to the risks and potential negative 
impacts of technology on nature and humans. It may be the only possible effective response 
to existential risk (Bostrom, 2002). One widely accepted formulation of the precautionary 
principle states: "when an activity raises threats of harm to human health or the 
environment, precautionary measures should be taken even if some cause and effect 
relationships are not fully established scientifically” (Raffensperger and Tickner, 1999, cited 
in  Kriebal, et al., 2001, p. 872). The precautionary principle is proposed as a guideline for 
decision-making. It has four main components: “taking preventative action in the face of 
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uncertainty; shifting the burden of proof to the proponents of an activity; exploring a wide 
range of alternatives to possible harmful actions; and increasing public participation in 
decision making” (Kriebal, et al., 2001, p. 872). The term ‘precautionary principle’ is an 
English translation of the German word Vorsorgeprinzip which might also be translated as 
‘foresight principle’, a translation which focuses on anticipatory action rather than the 
slightly more negative reactive focus of the English word ‘precaution’.  
The precautionary principle is, therefore, a teleological ethical approach. As noted earlier, 
genetic knowledge is still undergoing rapid discovery and revision. Suzuki (2001) pointed 
out that, considered today, the leading ideas of genetics in 1961 seem naïve and absurd. He 
made the further plausible claim that many of our current scientific ideas will ultimately be 
wrong, irrelevant or unimportant. From this, he concluded that the wise approach to 
technological development is to take a precautionary approach rather than rush to apply the 
latest ideas. However, such an approach does not necessarily come easily to scientists 
engaged in leading edge research. Scientists tend to have their focus on the good that could 
be accomplished from their discoveries (Small, 2011) Indeed, top experts tend to be overly 
optimistic about the technologies they are developing, often underestimating the risk 
associated with their field of work and underestimating realisation and diffusion problems 
(National Science Board, 1977; Rollin, 1996; Ticky, 2004). Less specialised experts were found 
to be less optimistic than top experts (Ticky, 2004). 
Small and Jollands (2006) also identified a third way in which technology may cause harm 
to nature and humans. This cause of technological harm they called malevolent. In this case, 
the technology is developed specifically to cause harm to humans or the environment. Thus, 
the ‘telos’ of such technologies is evil. Nuclear weapons and other weapons of mass 
destruction are examples of technologies whose telos is evil. Although gene technologies 
hold fantastic potential for public good and the benefit of humanity, they also hold fantastic 
potential for harm. In a worst case scenario, through accidental, incidental or malevolent 
causes, the result could be the demise of life on Earth (Bostrom, 2002; Joy, 2000; Rees, 2003). 
Much depends upon how and what humans choose to use powerful technologies for. As 
these technologies become increasingly accessible and available for use by all echelons of 
society, what humans choose to use these technologies for will be determined by the full 
range and extent of human nature and human behaviour, from the altruistic to the 
malevolent. In keeping with the advice of Jonas (1985) to give priority to the prophesy of 
doom over the prophesy of bliss, a problem that will have to be solved, sooner rather than 
later, is how to stop the potential malevolent applications of genetic technologies (some of 
which pose existential threats). 
4. Rights and responsibilities of science in society 
In the case of genetic engineering it is reasonably clear that some applications of the 
technology are almost universally acceptable to society (i.e., production of GE insulin raises 
almost no resistance), and medical applications are generally viewed with reasonable 
favour. Others, such as GE food raise greater deontological and teleological moral concern 
for society, but may not be rejected outright and are likely to be considered acceptable under 
some circumstances (Small, 2005; Small, et al., 2005). Human technology and actions are 
changing the ecological balance of the planet with some potential catastrophic outcomes 
(Lubchenco, 1998). Perhaps, if as suggested by Federoff (2010) and The Royal Society (2009), 
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GE technology will be able to help us address these issues, society will consider the 
circumstances appropriate. However, there are other GE technologies or potential products 
which society has greater moral trepidation about. The genetic engineering of animals is less 
acceptable than the genetic engineering of plants or crops, while the use of genetic 
engineering to enhance human potential is currently very unacceptable to society. Although, 
to my knowledge, there is no empirical data regarding the public acceptability of genetically 
engineered weapons of mass destruction, I would suggest that such use of the technology 
would be considered morally reprehensible by any right thinking person. 
A question that the analytical and empirical considerations discussed in this chapter raise is: 
What are the rights and responsibilities of science and scientists with respect to the wider 
society in regard to the development of controversial science and technologies such as 
genetic engineering? A common argument made by scientists working in the field of GE, 
when considering public criticism of the technology, is that the public are arguing from an 
emotional rather than a rational perspective and, therefore, their arguments should be 
dismissed. (As an aside, scientists too might have an emotional stake in the issue – 
attachment to years of education, passion for their field of science, justification of their own 
research endeavour and life path, and the social status and financial security provided by 
their career, etc.). 
 However, Small (2004b) argued that emotions are just as relevant to humans as rationality. 
Individuals grow up within a particular culture and are trained to adopt the culture’s 
explicit moral values and assimilate its tacit ones from an early age. These deeply 
embedded values comprise the core of an individual’s self identity and provide a lens 
through which they examine and evaluate the world and construct personal meaning. 
People have strong emotional attachments to their core values. To be human is to be both 
rational and emotional. To deny either of these components is to be less than human. 
Without our emotions our moral sensibilities would be severely diminish. If we do not 
respect people’s emotional experience then we are not respecting them. When it comes to 
understanding public acceptance of a technology and respecting people’s core values, it is 
essential that science consider how the technology will impact on people’s emotional, 
moral, cultural and spiritual sensibilities, as well as their rational reasoning (again 
emphasising the need to foresight the societal implications of new technologies from an 
understanding of human nature and behaviour). Responsible science is obligated to 
acknowledge, respect and appropriately incorporate the cultural, spiritual, and moral 
values of society. This may be an essential requirement for science to gain and maintain the 
trust and co-operation of society.  
Nonetheless, when considering the rights of science in society, Small (2004b) argued that 
moral beliefs about what is acceptable or unacceptable differ between cultures and societies, 
and between groups within a society. While some moral values enjoy almost unanimous 
support (e.g., murder is wrong) others may be more controversial (e.g., abortion is wrong). 
Similarly, cultures change and evolve over time, along with their moral values. Practices 
that were once commonplace, and consistent with the moral values of the time, are no 
longer acceptable in modern societies (or are becoming less so). Slavery, child labour, child 
marriages, drink driving, environmental pollution, and the death penalty are clear examples. 
Similarly, practices and values once unacceptable to society, have over time, become  
more morally acceptable, sometimes even enshrined in changed law. Clear examples  
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include religious freedom, freedom of speech, birth control, homosexuality, divorce, and 
children born outside traditional marriage (Svensson & Wood, 2003).  
Science and ethics are irrevocably intertwined. New knowledge, including that discovered 
by science, may help to change society’s moral, spiritual and cultural values and practices. 
Science has played a major role in the development of modern western culture and modern 
values. Two prime historical examples are Galileo’s proof of the Copernican heliocentric 
worldview and Darwin’s theory of evolution. These examples are particularly useful 
because they not only show how science has helped shape modern values but they also 
show that it can be important for scientists to challenge both the received scientific beliefs of 
the day and the received spiritual, cultural and moral values of the day. Demonstrating that 
the Earth revolves around the sun, Galileo removed humans from the physical centre of the 
universe. Darwin’s theory of evolution continued this revolution in thought, removing 
humans from the spiritual centre of the universe. These scientific theories changed our 
understanding of our place in nature. They have implications for the moral status of 
humans, non-human life, and the environment (Small, 2004b). 
Galileo and Darwin challenged not only the received scientific wisdom of their time but also 
the cultural, spiritual and moral norms. Both theories caused moral and religious outrage 
when first introduced. Today they are the received wisdom. With hindsight we can see that 
Galileo and Darwin’s beliefs were ahead of the rest of society. They are great figures in 
human history precisely because they had the courage to challenge not only contemporary 
scientific thought, but also the cultural spiritual and moral values of their time. An essential 
criterion for scientific progress is that the propositions and theories of science are open to 
challenge and revision in the light of new evidence. I propose that an important criterion for 
the evolution of cultural, spiritual and moral values is that they too are open to challenge 
from new knowledge and new ways of thinking about the world, including scientific progress. 
5. Conclusions 
I have argued that it is important for the science community to acknowledge, respect and 
incorporate the cultural, spiritual, and moral beliefs and values of society. I have also argued 
that, since such beliefs are not immutable, but change over time, it is equally important that 
science has the freedom to challenge the cultural, spiritual and moral values of society. As 
the examples of Galileo and Darwin illustrate, challenging values and beliefs is an important 
way in which science and culture change and progress. Indeed, perhaps raising such 
challenges is an important responsibility of science to society. The issue then becomes one of 
finding an appropriate balance between these two somewhat opposed objectives. Not every 
scientific challenge to the mores of society will eventually be accepted. Science and 
rationality are very powerful ways of knowing about the world, but they do not necessarily 
know better than culture, religion, emotion and morality in all situations. Rather, the 
arguments made above support a post-normal science approach to technological 
development; indicating the need for openness, debate and ongoing dialogue between 
science and society about the directions of science and society’s cultural, spiritual and moral 
imperatives. By being open and transparent and engaging in public dialogue and debate 
about controversial or leading edge scientific research, the science community not only 
demonstrates social responsibility but may also be on the leading edge of cultural, spiritual 
and moral evolution of society.  
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As argued by Jonas (1985), an essential component of this dialogue is the scientific 
foresighting of the potential biophysical, social and moral impacts of new technologies. In 
this way scientists can help the public understand the implications of new technologies with 
respect to the values they hold and the worldly objects they value. Bunge (1977) goes 
further, arguing that scientists should be held responsible and accountable for the uses to 
which their technological inventions are put and their impacts on society. It is certainly true 
that scientists are given credit and praise for the benefits that accrue from their technological 
inventions and this suggests that, conversely, they should be blamed and held accountable 
for the harms that accrue. However, in this context, there appears to be an asymmetry 
between credit and blame. This asymmetry is a consequence of two facts. First, scientists 
cannot control what others choose to do with the technologies that they develop, and 
second, as Jonas points out, despite the moral requirement for foresighting the implications 
and impacts of new technologies, foresight will always remain imperfect. Hence, in the 
development of powerful new technologies, such as genetic engineering, which have the 
potential to irrevocably alter human and non-human life, and planetary ecosystems forever, 
it is essential that the scientific community apply the precautionary principle. 
However, debate and dialogue between science and society, while being important moral 
imperatives for both the science community and the public, will not necessarily provide the 
science community with the most accurate understanding of public attitudes and values nor 
indicate the directions in which public mores are trending. Debate and dialogue tend to 
primarily engage individuals who gravitate to extreme positions leaving the majority 
unengaged and the subtleties of their positions unrecognised. The relatively new discipline 
of empirical ethics (Borry, Schotsmans, & Dierickx, 1995, 2005; Borry, et al., 2007) combines 
normative ethics with descriptive ethics. Descriptive ethics has a social science 
methodological basis, anchored in the disciplines of sociology, anthropology, psychology 
and epidemiology, and using qualitative and quantitative scientific methods. The aim of 
empirical ethics is to combine descriptive ethics understandings of various different publics 
with the analytical insights of normative ethics to produce contextually relevant moral 
decisions (Borry, et al., 2007). Post-normal science and empirical ethics may provide 
methodologically sound techniques for increasing transparency about the social and moral 
implication of genetic engineering. 
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